News

Can cognitive therapy treat depression?

People with MS are more likely to suffer from depression than the general community, especially when newly diagnosed. Whilst there are a number of psychological treatments available, there are only a few designed specifically for depression in people with MS. Researchers at the University of Melbourne would like to address this and are conducting a trial directly comparing two different therapies, a cognitive behavioural therapy, which is a talk therapy the helps individuals learn skills about thinking and behaviour, and a supportive listening therapy, which is another type of talk therapy that involves talking about your problems.

This cognitive therapy trial is called ACTION-MS and currently recruiting people newly diagnosed with MS, (diagnosed in the last 5 years) who are able to travel to the Royal Melbourne Hospital to participate. If you would like to find out more information about this MS trial or see if there are other trials that you can participate in please visit the website.

There are MS trials run all around Australia and new trials are listed on the website regularly. The range of clinical trials listed on the website is broad and can involve as little as filling in an online questionnaire at home through to participating in drug trials testing new drugs.

It is important if you are considering getting involved in a study, particularly where it may affect other medications that you are taking, to talk to your treating doctor first. But getting involved in research is easy and it is of great benefit to the whole MS community. Together we can do so much more.

About AHSCT – current thinking

There have been recent positive steps forward for people with MS considering AHSCT. Read the current thinking towards AHSCT for people with MS.

Research conferences: shaping the future of MS

CEO Rohan Greenland gives an update on the MS Australia activities for October, focusing on the world's largest MS research conference ECTRIMS and the importance of conferences in shaping the future of MS.

Sarah’s tribute to MS research

In 2015 Sarah's life changed completely when she was diagnosed with multiple sclerosis, she is now on a mission to raise funds to power MS research.

Does “MS fatigue” capture the symptom experience?

The International Progressive MS Alliance has recently highlighted that very little progress has been made in treating and understanding MS fatigue.

DMTs: Impact of access on quality of life

MS Australia's advocacy efforts have contributed to a number of subsidised MS medications and disease-modifying therapies (DMTs). New research now shows the effect this has on the outcomes for people living with MS in New Zealand.

Submissions: an important advocacy tool

As part of our advocacy work at MS Australia, we make many submissions each year, to various Australian Government inquiries and consultations.

What us to keep you in the loop? Subscribe today!

  • Enter your details
Read More

Newsletter subscription

  • Enter your details

Can cognitive therapy treat depression?